Late-onset neurofibromatosis in a liver transplant recipient

International Journal of Dermatology

Volumn 39, Issue 5, 2000, Pages 376-379

  Miller, Martin B ^a   Tonsgard, James H ^a   Soltani, Keyoumars ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HEMODIALYSIS; HUMAN; LIVER TRANSPLANTATION; MALE; NEUROFIBROMATOSIS; PRURITUS; ULTRAVIOLET B RADIATION;

EID: 0034032364     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00841-5.x     Document Type: Article

References (22)

1. Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Prob Cancer 1982; 7: 1-34.
2. Riccardi VM. Neurofibromatosis. Phenotype, Natural History and Pathogenesis, 2nd edn. Baltimore, MD: Johns Hopkins University Press, 1995: 236-248.
3. Crowe FW, Schull WJ, Neel JV. A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatoses. Springfield: Charles C Thomas, 1956: 171.
4. Viskochil D, Buchberg AM, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62: 187-192.
5. Marchuk DA, Saulino AM, Tavakkol R, et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991; 11: 931-940.
6. Neurofibromatosis Conference Statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-578.
7. Martuza RL, Eldridge R. Neurofibromatosis 2. N Engl J Med 1988; 318: 684-688.
8. Riccardi VM. Neurofibromatosis in a patient with systemic lupus erythematosus. Arthr Rheum 1983; 26: 574.
9. Trattner A, David M, Ingber A, Sandbank M. Coexistence of late-onset neurofibromatosis and cutaneous T cell lymphoma. J Am Acad Dermatol 1990; 23: 932-934.
10. Nishimura M. Late-onset neurofibromas developed in a patient with psoriasis vulgaris during PUVA treatment. Arch Dermatol 1990; 126: 541-542.
11. Menon AG, Anderson KM, Riccardi VM, et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 1990; 87: 5435-5439.
12. Theiler R, Stocker H, Boltshauser E. Zur Klassierung atypischer Neurofibromatose-Formen. Schweiz Med Wschr 1991; 121: 446-455.
13. Tonsgard JH, Kwak SM, Short MP, Dachman A. CT imaging in adults with neurofibromatosis-1. Frequent asymptomatic plexiform lesions. Neurology 1998; 50: 1755-1760.
14. Riccardi VM. Type 1 neurofibromatosis and the pediatric patient. Curr Prob Pediatr 1992; 22: 66-106.
15. Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989; 114: 788-792.
16. Huson SM, Harper PS, Compston DAS. von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain 1988; 111: 1355-1381.
17. Bollag G, McCormick F. NF is enough of GAP. Nature 1995; 356: 663-664.
18. Xu G, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and component ira mutants of S. cerevisiae. Cell 1990; 63: 835.
19. Guttmann DH, Collins FS. von Recklinghausen neurofibromatosis. In: The Metabolic and Molecular Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 677-696.
20. Coleman SD, Wallace MR. Neurofibromatosis type 1. Eur J Cancer 1994; 30: 1974-1981.
21. Nakamura T, Hara M, Kasuga T. Early lesion of N-nitroso-N-ethylurea-induced hamster neurofibromatosis model. Cancer Res 1991; 51: 434-438.
22. Wijdicks EF, Jambroes G, Riccardi VM. De novo astrocytoma following immunosuppression in neurofibromatosis. Neurology 1990; 40: 1467-1468.